Arvinas, Inc. (ARVN)
9.09
-0.01
(-0.11%)
USD |
NASDAQ |
May 22, 16:00
9.09
0.00 (0.00%)
After-Hours: 20:00
Arvinas EPS Diluted (Quarterly) : -0.90 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.4688 |
| Rigel Pharmaceuticals, Inc. | 0.4396 |
| EyePoint, Inc. | -0.9864 |
| Elanco Animal Health, Inc. | 0.1126 |
| Corcept Therapeutics, Inc. | -0.2988 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -57.60M |
| Revenue (Quarterly) | 15.60M |
| Total Expenses (Quarterly) | 73.20M |
| Enterprise Value | -19.80M |
| Gross Profit Margin (Quarterly) | 92.95% |
| Profit Margin (Quarterly) | -369.2% |
| Earnings Yield | -35.82% |
| Normalized Earnings Yield | -35.26 |